- Wall Street analysts have updated their ratings on several companies, including Intel Corp, Arrow Financial Corp, Boost Run Inc, Tonix Pharmaceuticals Holding Corp, and Castle Biosciences Inc.
- Goldman Sachs initiated coverage on Intel with a Neutral rating and a $150 price target, while other firms also provided various ratings and targets.
- This trend indicates a mixed outlook across different sectors, with some stocks receiving bullish ratings and others marked as market performers or neutral.
